short-range nuclear missiles aimed at South Korea and vowed to improve them by making the warheads “smaller, lighter and tactical.” South Korea’s strategy of deterrence has been based on the belief that the best chance it has against the North without nuclear weapons of its own is to build up a conventional missile defense and deploy ever more powerful “bunker busters” to make Mr. Kim fear for his life.

When North Korea tested its intercontinental ballistic missile in 2017, the United States and South Korea responded by launching their own ballistic missiles to demonstrate their “deep-strike precision” capabilities. In his book “Rage,” the journalist Bob Woodward wrote that the American missile traveled the exact distance between its launching point and the location from which Mr. Kim watched his I.C.B.M. launch.

collapsed, North Korea resumed tests in 2019, rolling out three short-range ballistic missiles that were designed to counter the allies’ antimissile capabilities.

North Korea’s old fleet of Scud and Rodong missiles used liquid fuel and lacked precision. The country’s new generation of missiles uses solid propellants, making them quicker to launch, easier to transport and more difficult to target. They also have greater accuracy and evasive maneuvering power that could confound the South’s missile defense systems.

The new solid-fuel ballistic missile North Korea tested in March likely evaded the allies’ radar during its low-altitude maneuvering, leading the South Korean military to estimate its range at 280 miles, not the 372 miles the North claimed, said Chang Young-keun, a missile expert at Korea Aerospace University. Mr. Chang said the missile could also likely increase range and warhead weight because it was powered by “the largest solid-fuel rocket motor developed and tested in North Korea so far.”

The North’s ICBMs still use liquid fuel, which takes hours to load before launching, making them vulnerable to American pre-emptive strikes. But in his January speech, Mr. Kim vowed to build solid-fuel ICBMs, presenting an even bigger challenge for American missile defenses. Such prospects deepen the fear among some South Koreans that Washington would be less likely to intervene if it, too, faced a possible North Korean nuclear attack.

View Source

C.D.C. Panel to Meet Next Friday on J.&J. Vaccine Pause

The federal government’s call for a pause on using Johnson & Johnson’s coronavirus vaccine could last at least another week, further complicating efforts by federal and state health officials to reschedule appointments, and reassure jittery Americans that the vaccine is safe and effective.

The Centers for Disease Control and Prevention’s independent vaccine advisory panel, known as the Advisory Committee on Immunization Practices, or ACIP, has been scheduled to meet for a second time since shots were halted, next Friday, to discuss safety data related to a small number of blood-clotting cases in Johnson & Johnson vaccine recipients. It is unclear whether the vaccine was responsible for the clots.

The public, six-hour meeting could conclude with a vote, for example, to recommend to continue the pause, to modify the F.D.A.’s authorization of the single-dose vaccine or to rescind the pause altogether. The federal government could then act quickly to follow the guidance.

“We recognize the critical importance of moving quickly. That’s why we will have two unscheduled ACIP meetings in a 10-day period,” Dr. Rochelle P. Walensky, the C.D.C. director, said at a White House news conference Friday.

decided Wednesday to wait on a vote while they take more time to assess a possible link to the rare but serious blood-clotting disorder.

Dr. Anthony S. Fauci, the government’s top infectious disease expert, told lawmakers at a hearing on Thursday that “hopefully we’ll get a decision quite soon as to whether or not we can get back on track with this very effective vaccine.” State health departments have rescheduled appointments and substituted two-dose vaccines made by Pfizer-BioNTech and Moderna — a plan that White House officials have referenced as a quick way to make up for the gap.

While Johnson & Johnson’s vaccine has accounted for a fraction of U.S. vaccinations, it has been a key tool in the Biden administration’s strategy. The shot can be kept at normal refrigeration temperatures for three months, and at one dose, allowed for people to dispense with vaccination in a single go. Some public health officials worry the pause may deepen hesitancy. And there are concerns about the risks posed to the global vaccination drive in countries that can ill afford to be particular about shots.

In the United States, the pause has had immediate and dire consequences for local officials, who have worked to vaccinate vulnerable populations with the shot: homeless people in Baltimore, homebound residents in the District of Columbia, the poor and uninsured in Massachusetts and rural residents in a number of states.

have received the Johnson & Johnson shot, with around 10 million doses currently unused.

Setbacks with the vaccine, including a mix-up in a Baltimore plant that recently contaminated up to 15 million doses of it, have caused the White House to revise its math in projecting when the nation will have enough doses to cover every American adult, which President Biden had predicted would happen by the end of May.

The White House press secretary, Jen Psaki, said on Thursday that there would be enough doses to cover 80 percent of the adult population by that point, or likely enough for every adult who wants one. She added that there would be enough for 90 percent of the population by the end of July.

Sheryl Gay Stolberg, Daniel E. Slotnik and Sharon Otterman contributed reporting.

View Source

A New ‘Denim Cycle’? After a Decade, Jeans Move From Skinny to Loose

The trend is not confined to Levi’s, which lays claim to inventing the blue jean in 1873. Madewell, the popular retail chain owned by J. Crew Group, has also been seeing enthusiasm around looser fit jeans and balloon pants, even among skinny jean acolytes, which is viewed as a turning point for the fit.

“The people who were really long holding onto skinnies are like ‘Oh OK, I’m going to crawl over to the other side and do something,’” said Anne Crisafulli, Madewell’s senior vice president of merchandising.

Madewell, which is known for its jeans, has been coming up with styles that help customers transition to the looser fit in a bid to provide “training wheels for people coming out of skinny,” Ms. Crisafulli said. Customers seem to want “looser and more comfortable” denim going forward, she added.

Mr. Bergh noted that pandemic-related weight gain could be driving interest in the jeans, as some people look to update their closets.

Levi’s, based in San Francisco, saw its revenue tumble 23 percent to $4.45 billion in 2020, as many retailers saw sales fall as stores faced temporary closures and customer habits shifted. Sales also dropped in the first quarter, which ends in February, but Mr. Bergh noted that was before vaccines had been rolled out in the United States in a “big way.” He said he was optimistic about a denim resurgence.

“As people think about going back out, they’re thinking about what’s the look now, and they’re going to our website, they’re going to other websites, looking at fashion magazines and seeing looser, baggier fits be the new trend,” Mr. Bergh said. “The fact that people are liberated and can finally go out to dinner with their family or girlfriend or boyfriend — it gives them an occasion to kind of upgrade their wardrobe, update the look and splurge a little bit on themselves, and I think that’s what we’re seeing.”

And still, even if looser denim is the look of the 2020s, that does not mean the disappearance of the skinny jean.

“I don’t think skinny jeans are ever going to go away completely,” Mr. Bergh said. “People are mixing it up, and women in particular are having multiple choices.”

View Source

How Mario Draghi Has Made Italy a Power Player in Europe

ROME — The European Union was stumbling through a Covid-19 vaccine rollout marred by shortages and logistical bungling in late March when Mario Draghi took matters into his own hands. The new Italian prime minister seized a shipment of vaccines destined for Australia — and along with them, an opportunity to show that a new, aggressive and potent force had arrived in the European bloc.

The move shook up a Brussels leadership that had seemed to be asleep at the switch. Within weeks, in part from his pressing and engineering behind the scenes, the European Union had authorized even broader and harsher measures to curb exports of Covid-19 vaccines badly needed in Europe. The Australia experiment, as officials in Brussels and Italy call it, was a turning point, both for Europe and Italy.

It also demonstrated that Mr. Draghi, renowned as the former European Central Bank president who helped save the euro, was prepared to lead Europe from behind, where Italy has found itself for years, lagging behind its European partners in economic dynamism and much-needed reforms.

In his short time in office — he took power in February after a political crisis — Mr. Draghi has quickly leveraged his European relationships, his skill in navigating E.U. institutions and his nearly messianic reputation to make Italy a player on the continent in a way it has not been in decades.

denied her a chair, rather than a sofa, during a visit to Turkey last week, saying he was “very sorry for the humiliation.”

In his debut in a European meeting as Italy’s prime minister in February, Mr. Draghi, 73, made it clear that he was not there to cheerlead. He told an economic summit including heavy hitters like his European Central Bank successor, Christine Lagarde, to “curb your enthusiasm” when it came to talk about a closer fiscal union.

That sort of union is Mr. Draghi’s long-term ambition. But before he can get anywhere near that, or tackle deep economic problems at home, those around him say Mr. Draghi is keenly aware that his priority needs to be solving Europe’s response to the pandemic.

Italian officials say his distance from the contract negotiations, which were completed before he took office, gave him a freedom to act. He suggested that AstraZeneca had misled the bloc about its supply of vaccine, selling Europe the same doses two or three times, and he immediately zeroed in on an export ban.

“He understood straightaway that the issue was vaccinations and the problem was supplies,” said Lia Quartapelle, a member of Parliament in charge of foreign affairs for Italy’s Democratic Party.

On Feb. 25, he joined a European Council videoconference with Ms. von der Leyen and other European Union leaders. The heads of state warmly welcomed him. “We owe you so much,” Bulgaria’s prime minister told him.

Then Ms. von der Leyen gave an optimistic slide presentation about Europe’s vaccine rollout. But the new member of the club bluntly told Ms. von der Leyen that he found her vaccine forecast “hardly reassuring” and that he didn’t know whether the numbers promised by AstraZeneca could be trusted, according to an official present at the meeting.

He implored Brussels to get tougher and go faster.

Ms. Merkel joined him in scrutinizing Ms. von der Leyen’s numbers, which put the Commission president, a former German defense minister, on the back foot. Mr. Macron, who had championed Ms. von der Leyen’s nomination but quickly formed a strategic alliance with Mr. Draghi, piled on. He urged Brussels, which had negotiated the vaccine contracts on behalf of its members, to “put pressure on corporations not complying.”

At the time, Ms. von der Leyen was coming under withering criticism in Germany for her perceived weakness on the vaccine issue, even as her own commissioners argued that responding too aggressively with a vaccine export ban could hurt the bloc down the road.

Mr. Draghi, with his direct talk during the February meeting, tightened the screws. So did Mr. Macron, who has emerged as his partner — the two are dubbed “Dracon” by the Germans — pushing for a more muscular Europe.

Behind the scenes, Mr. Draghi complemented his more public hard line with a courting campaign. The Italian, who is known to privately call European leaders and pharmaceutical chief executives on their cellphones, reached out to Ms. von der Leyen.

Of all the players in Europe, he knew her the least well, according to European Commission and Italian officials, and he wanted to remedy that and make sure she did not feel isolated.

Then, in early March, as shortages of AstraZeneca’s Covid vaccine continued to disrupt Europe’s rollout and increase public frustration and political pressure, Mr. Draghi found the perfect gift for Ms. von der Leyen: 250,000 doses of seized AstraZeneca vaccine earmarked for Australia.

“He told me that in the days before he was on the phone a lot with von der Leyen,” said Ms. Quartapelle, who spoke with Mr. Draghi the day after the shipment freeze. “He worked a lot with von der Leyen to convince her.”

The move was appreciated in Brussels, according to officials in the Commission, because it took the onus off Ms. von der Leyen and gave her political cover while simultaneously allowing her to seem tough for signing off on it.

The episode has become a clear example of how Mr. Draghi builds relationships with the potential to yield big payoffs not only for himself and Italy, but all of Europe.

On March 25, when the Commission became suspicious over 29 million AstraZeneca doses in a warehouse outside Rome, Ms. von der Leyen called Mr. Draghi for help, officials with knowledge of the calls said. He obliged, and the police were quickly dispatched.

In the meantime, Mr. Draghi and Mr. Macron, joined by Spain and others, continued to support a harder line from the Commission on vaccine exports. The Netherlands was against it, and Germany, with a vibrant pharmaceutical market, was queasy.

When the European leaders met again in a video conference on March 25, Ms. von der Leyen seemed more confident in the political and pragmatic advantages of halting exports of Covid vaccines made in the European Union. She again presented slides, this time authorizing a broader six-week curb on exports from the bloc, and Mr. Draghi stepped back into a supportive role.

“Let me thank you for all the work that has been done,” he said.

After the meeting, Mr. Draghi, however modestly, gave Italy — and by extension himself — credit for the steps allowing export bans. “This is more or less the discussion that took place,” he told reporters, “because this was the issue originally raised by us.”

View Source

With Afghan Decision, Biden Seeks to Focus U.S. on New Challenges

WASHINGTON — President Biden’s decision to pull all American troops from Afghanistan by Sept. 11 was rooted in his belief that there is no room for continuing 20 years of failed efforts to remake that country, especially at a moment when he wants the United States focused on a transformational economic and social agenda at home and other fast-evolving threats from abroad.

Though Mr. Biden would never use the term, getting out of Afghanistan is part of his own version of “America First,” one that differs drastically from how his predecessor, Donald J. Trump, used the phrase. His years on the Senate Foreign Relations Committee and as vice president convinced him that the United States-led effort in Afghanistan was destined to collapse of its own weight.

Time and again during the Obama administration, Mr. Biden lost arguments to reduce the American presence to a minimal counterterrorism force. But after less than three months as president, Mr. Biden came to the determination that only a full withdrawal — with no link to political conditions on the ground — would wrench America’s attention away from the conflict of the past two decades in favor of the very different kinds he expects in the next two.

He has defined his presidency’s goals as releasing the country from the grip of a virus that is morphing into new variants, seizing an opportunity to bolster economic competitiveness against China and proving to the world that American democracy can still rise to great challenges.

annual worldwide threat assessment published by his intelligence chiefs on Tuesday morning, as word of his decision leaked, explicitly warned that “the Afghan government will struggle to hold the Taliban at bay” if the American-led coalition withdraws. Administration officials said that raised the specter of something akin to the 1975 fall of Saigon, after the United States gave up on another ill-considered war.

But Mr. Biden’s decision makes clear his belief that contending with a rising China takes precedence over the idea that with just a few more years in Afghanistan, and a few more billions of dollars, the United States could achieve with a few thousand troops what it could not achieve with hundreds of thousands and the more than $2 trillion already poured into two decades of warfighting and nation building.

After Mr. Biden declared at a news conference last month that “We’ve got to prove democracy works,” he went on to describe a foreign policy that was focused on restoring America’s reputation for getting big things done. “China is outinvesting us by a long shot,” the president noted, “because their plan is to own that future.”

Indeed, no one celebrated the American involvement in Afghanistan, or Iraq, more than the Chinese — conflicts that kept Americans up at night worrying about casualties and taking control of distant provinces, while Beijing focused on spreading its influence in regions of the world where America was once the unquestioned dominant power.

Afghanistan’s stability deeply in jeopardy. If there is no terrorist attack launched from Afghan territory again, no echo of Sep. 11, 2001, Mr. Biden may well have been judged to have made the right bet.

In the end, the argument that won the day is that the future of Kenosha is more important than defending Kabul. And if Mr. Biden can truly focus the country on far bigger strategic challenges — in space and cyberspace, against declining powers like Russia and rising ones like China — he will have finally moved the country out of its post-9/11 fixation, where counterterrorism overrode every other foreign policy and domestic imperative.

That would be a real change in the way Americans think about the purpose of the country’s influence and power, and the nature of national security.

View Source

Amazon Workers Defeat Union Effort in Alabama

The vote could lead to a rethinking of strategy inside the labor movement.

For years, union organizers have tried to leverage growing concerns about low-wage workers to break into Amazon. The Retail, Wholesale and Department Store Union had organized around critical themes of supporting Black essential workers in the pandemic. The union had estimated that 85 percent of the workers at the Bessemer warehouse were Black.

The inability to organize the warehouse also follows decades of unsuccessful and costly attempts to form unions at Walmart, the only American company that employs more people than Amazon. The repeated failures at two huge companies may push labor organizers to focus more on backing national policies, such as a higher federal minimum wage, than unionizing individual workplaces.

Democrats in Washington, who put their full weight behind the union effort, said the loss showed that they needed to push for changes to labor and antitrust laws. The House of Representatives passed an expansion of worker protections this year, but it is unlikely to be approved in the Senate.

“Workers cannot organize to scale in America absent labor law reform, full stop,” Representative Andy Levin of Michigan, who had visited Bessemer, said in an interview.

The Amazon warehouse, on the outskirts of Birmingham, opened a year ago, just as the pandemic took hold. It was part of a major expansion at the company that accelerated during the pandemic. Last year, Amazon grew by more than 400,000 employees in the United States, where it now has almost a million workers. Warehouse workers typically assemble and box up orders of items for customers.

The unionization effort came together quickly, especially for one aimed at such a large target. A small group of workers at the building in Bessemer approached the local branch of the retail workers’ union last summer. They were frustrated with how Amazon constantly monitored every second of their workday through technology and felt that their managers were not willing to listen to their complaints.

Organizers appeared to have strong support early on, getting at least 2,000 workers to sign cards saying they wanted an election, enough for the National Labor Relations Board, which conducts union elections, to approve a vote.

View Source

For Bonds, Add Safety by Venturing Abroad

Making your bond-fund portfolio less risky requires doing something that can feel like living dangerously: investing abroad.

If you’re like most people, you may have put too much of your money in bond funds invested in your home market and so failed to spread your bets around.

“People are used to thinking about diversification in their stock portfolio, and they understand how that works to control the risk,” said Rob Waldner, chief strategist for fixed income at Invesco. “You need to do that with your fixed income, too.”

Bond diversification matters all the more when traditional income producers like U.S. Treasuries are paying measly rates, he said.

1.7 percent in early April, compared with less than 1 percent in January. But rates are likely to remain relatively low by long-term standards.

Bonds come in a variety as rich — and sometimes baffling — as the screw-and-fastener aisle at Home Depot.

A well-diversified portfolio might include mutual funds or exchange-traded funds that buy bonds issued by the United States and foreign governments, and large U.S. and foreign companies, as well as ones backed by mortgages, auto loans or credit-card receivables in the United States. (Pools of these financial assets are securitized, and rights to payments from the pools become mortgage-backed and asset-backed bonds.)

“Home bias” is the financial term for people’s tendency to over-invest in their home market and shy from other places. Investment experts say it’s pervasive.

“It’s something we observe in every country,” said Roger Aliaga-Diaz, global head of portfolio construction at Vanguard.

Vanguard’s research has found that international bonds reduce portfolios’ ups and downs without hurting the total return. Internationally diversifying can provide access to securities from more than 40 countries.

“This broad exposure is important, as the factors that drive international bond prices are relatively uncorrelated to those that drive prices in the U.S.,” the report said. Lately, for example, South Korea’s 10-year government bond is yielding 2 percent, while Mexico’s is yielding nearly 7 percent.

The international bond slice of Vanguard’s target-date funds is invested in the Vanguard Total International Bond Index Fund, which owns mainly developed-world bonds. Like many international bond funds, it uses hedging to protect its shareholders against the return volatility that currency fluctuations can cause.

Jean Boivin, head of the BlackRock Investment Institute, said his outfit’s research suggests that investors may want to be bold in their foreign bond forays and look beyond developed markets.

“You need to think about emerging-market bonds and, in particular, Asia ex-Japan,” he said.

In the past, investors could view the U.S. bond market as a proxy for the world, partly because U.S. companies often had sprawling international operations, Mr. Boivin said. But there is enormous global diversity today. Foreign markets, especially China, have risen so much that this approach doesn’t work as well.

Total Return Fund might provide a starting point for considering reasonable ranges. It recently allocated about 8.6 percent of its assets to emerging markets.

The Fidelity Total Bond Fund, another broad offering, lately had a 16 percent stake in higher-yielding, riskier kinds of domestic and foreign debt.

“Historically, we’ve owned from 8 to 18 percent in the higher-yielding sectors,” said Celso Munoz, one of the fund’s managers. “It’s appropriate for most people to have exposure to the broader fixed-income world, which would include high yield, emerging markets and bank loans.”

People may tend to shun international bonds partly because stocks overshadow bonds in the popular media, said Kathy Jones, chief fixed-income strategist at the Schwab Center for Financial Research.

“Every day somebody is talking about the S&P 500 or the Dow,” she said. “People don’t talk like that about Bloomberg Barclays U.S. Aggregate Bond Index,” a leading bond index, and relatively few people plunge even deeper into the fixed-income universe.

To decide how you might better diversify your bond funds, it helps to reflect on why you own them, said Tad Rivelle, chief investment officer for fixed income at TCW.

“The existential question is do you think of fixed income as a safe asset that enables you to take risk elsewhere,” he said, “or do you expect your bonds to pull their own weight, and so you’re OK with them going down in a market panic?”

MetWest Total Return Bond Fund might work for the first group, and its MetWest Flexible Income Fund for the second.

A puzzle for all bond-fund investors is how the end of the Covid-19 pandemic might affect interest rates.

Rates usually rise when the economy grows, as it’s expected to do as the world emerges from the pandemic. As that happens, inflation may rise, which could stifle a long bull market in bonds. Bond prices rise as interest rates fall.

Yet renewed inflation has been erroneously predicted before, and Jerome Powell, the chair of the Federal Reserve, has made clear that the bank isn’t rushing to raise the short-term rates it controls.

For investors who are counting on their bond funds for income, continued low rates could create a temptation to court risk.

A more patient approach is prudent, said Mary Ellen Stanek, chief investment officer for Baird Advisors, which oversees the Baird Funds.

“You don’t own bonds for excitement and drama,” she said. “You own them for predictability and lower volatility.”

Ms. Jones of Schwab warned, too, against seeking excessive risk. She suggested investors instead rethink how they take cash from their portfolios.

“In a year when your stocks are up 20 percent and your bonds are up 2, you may want to pull out some of those capital gains and put them in your cash bucket,” she said. “Say you’re looking to generate 6 percent overall, and you’ve made 20 percent in stocks. If you have excess above your plan, you can look at that as potential income.”

No matter what path investors choose, they should always pay close attention to the costs of funds and E.T.F.s, said Jennifer Ellison, a financial adviser at Bingham, Osborn & Scarborough in San Francisco.

“Costs are really important, especially with yields where they are,” since those costs will eat up much of that scant yield, she said. “If you’re a retail investor and you’re buying a loaded bond fund, you’re giving all your yield away up front.”


View Source

AstraZeneca Vaccine Faces New Setbacks in U.K. and European Union

LONDON — Britain said on Wednesday that it would curb the use of AstraZeneca’s vaccine in adults under 30 because of the risk of rare blood clots, a blow to the efforts of scores of countries reliant on the vaccine to stamp out the coronavirus pandemic amid a global surge in cases.

Adding to the unease, the European Medicines Agency outlined a “possible link” between the vaccine and rare clots, even as it said that Covid-19 remained the far greater threat, leaving decisions about how to use the vaccine in the hands of the 27 member states of the European Union.

Taken together, the decisions represented a considerable setback for the AstraZeneca shot, which has been seen as the principal weapon in the battle to reduce deaths in the vaccine-starved global south.

The world’s most widely administered coronavirus vaccine, it is far less expensive and easier to store than some of the alternatives, spurring its use in at least 111 countries, rich and poor. AstraZeneca, based in Britain, has promised to deliver three billion doses this year, enough to inoculate nearly one in five people worldwide.

Cameroon and the Democratic Republic of Congo have already delayed injections of AstraZeneca’s vaccine amid mounting concerns in Europe. Any further hesitation, scientists said, could cost lives.

“In developing countries, the dynamic is to either use the vaccine you have, or you have nothing,” said Penny Ward, a visiting professor in pharmaceutical medicine at King’s College London. “In which case, carnage ensues.”

For the vast majority of people, British and European regulators said on Wednesday, the benefits of AstraZeneca’s shot far outweigh the risks. The clotting problems were appearing at a rate of roughly one in 100,000 recipients across Europe. Meanwhile, in Britain, the vaccine has driven down hospitalizations from Covid-19 — which can, itself, cause serious clotting problems — and saved thousands of lives, regulators said.

most people doubted the vaccine’s safety.

Over all, use of the shot has suffered: Across Europe, 64 percent of delivered doses of AstraZeneca’s vaccine have been injected into people’s arms, markedly lower than the rates for other shots.

“One hoped there would have been collaboration, and more discussion, between regulators, instead of lots of different countries going off in all sorts of directions,” Professor Ward said. “That aspect has really been the most unhelpful.”

watch for certain symptoms, including severe and persistent headaches and tiny blood spots under the skin. Doctors’ groups have circulated guidance about how to treat the disorder.

As of March 22, regulators had carried out detailed review of 86 cases, 18 of which were fatal, they said.

Concerns about the shot became acute enough in Britain this week that the University of Oxford, which developed the vaccine with AstraZeneca, stopped giving doses as part of a two-month-old trial in children.

“Safety has been our priority throughout the development of the vaccine,” Andrew Pollard, the Oxford researcher in charge of the trials, said on Wednesday. The identification of the clots, he added, “shows that the safety system works.”

In the United States, AstraZeneca is preparing to apply for emergency use authorization from the Food and Drug Administration. If and when they take up the application, that agency’s regulators are expected to scrutinize the clotting cases.

The United States, flush with vaccines from three other makers, may not ultimately need AstraZeneca’s shot. But any ruling by the F.D.A. is expected to hold considerable weight in some of the poorer nations that are relying on the shot.

The World Health Organization said a vaccine safety subcommittee had met on Wednesday and noted that “rare adverse events following immunizations should be assessed against the risk of deaths from Covid-19 disease and the potential of the vaccines to prevent infections.” It said that a link with the clotting problems, while “plausible,” had not been confirmed.

For Britain, the AstraZeneca vaccine has become a huge source of national pride, and the backbone of the country’s speedy inoculation program.

Even if younger people are at lower risk from severe Covid-19, scientists have said, inoculating them remains essential to creating enough protection in the population to end the pandemic.

Emma Bubola, Monika Pronczuk and Rebecca Robbins contributed reporting.

View Source

AstraZeneca Vaccine Faces Setbacks in U.K. and European Union

LONDON — Britain said on Wednesday that it would curb the use of AstraZeneca’s vaccine in adults under 30 because of the risk of rare blood clots, a blow to the efforts of scores of countries reliant on the vaccine to stamp out the coronavirus pandemic amid a global surge in cases.

Adding to the unease, the European Medicines Agency outlined a “possible link” between the vaccine and rare clots, even as it said that Covid-19 remained the far greater threat, leaving decisions about how to use the vaccine in the hands of the 27 member states of the European Union.

Taken together, the decisions represented a considerable setback for the AstraZeneca shot, which has been seen as the principal weapon in the battle to reduce deaths in the vaccine-starved global south.

The world’s most widely administered coronavirus vaccine, it is far less expensive and easier to store than some of the alternatives, spurring its use in at least 111 countries, rich and poor. AstraZeneca, based in Britain, has promised to deliver three billion doses this year, enough to inoculate nearly one in five people worldwide.

Cameroon and the Democratic Republic of Congo have already delayed injections of AstraZeneca’s vaccine amid mounting concerns in Europe. Any further hesitation, scientists said, could cost lives.

“In developing countries, the dynamic is to either use the vaccine you have, or you have nothing,” said Penny Ward, a visiting professor in pharmaceutical medicine at King’s College London. “In which case, carnage ensues.”

For the vast majority of people, British and European regulators said on Wednesday, the benefits of AstraZeneca’s shot far outweigh the risks. The clotting problems were appearing at a rate of roughly one in 100,000 recipients across Europe. Meanwhile, in Britain, the vaccine has driven down hospitalizations from Covid-19 — which can, itself, cause serious clotting problems — and saved thousands of lives, regulators said.

most people doubted the vaccine’s safety.

Over all, use of the shot has suffered: Across Europe, 64 percent of delivered doses of AstraZeneca’s vaccine have been injected into people’s arms, markedly lower than the rates for other shots.

“One hoped there would have been collaboration, and more discussion, between regulators, instead of lots of different countries going off in all sorts of directions,” Professor Ward said. “That aspect has really been the most unhelpful.”

watch for certain symptoms, including severe and persistent headaches and tiny blood spots under the skin. Doctors’ groups have circulated guidance about how to treat the disorder.

As of March 22, regulators had carried out detailed review of 86 cases, 18 of which were fatal, they said.

Concerns about the shot became acute enough in Britain this week that the University of Oxford, which developed the vaccine with AstraZeneca, stopped giving doses as part of a two-month-old trial in children.

“Safety has been our priority throughout the development of the vaccine,” Andrew Pollard, the Oxford researcher in charge of the trials, said on Wednesday. The identification of the clots, he added, “shows that the safety system works.”

In the United States, AstraZeneca is preparing to apply for emergency use authorization from the Food and Drug Administration. If and when they take up the application, that agency’s regulators are expected to scrutinize the clotting cases.

The United States, flush with vaccines from three other makers, may not ultimately need AstraZeneca’s shot. But any ruling by the F.D.A. is expected to hold considerable weight in some of the poorer nations that are relying on the shot.

The World Health Organization said a vaccine safety subcommittee had met on Wednesday and noted that “rare adverse events following immunizations should be assessed against the risk of deaths from Covid-19 disease and the potential of the vaccines to prevent infections.” It said that a link with the clotting problems, while “plausible,” had not been confirmed.

For Britain, the AstraZeneca vaccine has become a huge source of national pride, and the backbone of the country’s speedy inoculation program.

Even if younger people are at lower risk from severe Covid-19, scientists have said, inoculating them remains essential to creating enough protection in the population to end the pandemic.

Emma Bubola, Monika Pronczuk and Rebecca Robbins contributed reporting.

View Source

Covid-19 Live Updates: U.S. Vaccinations Accelerate as Variants Linger

three million doses are being given on average each day, compared with well under one million when Mr. Biden took office in January, according to the Centers for Disease Control and Prevention. Every state has now given at least one dose to a quarter or more of its population. About 62.4 million people — 19 percent of Americans — have been fully vaccinated.

“Today, we are pleased to announce another acceleration of the vaccine eligibility phases to earlier than anticipated,” Gov. Larry Hogan of Maryland said on Monday, announcing that all Maryland residents 16 or older would be eligible from Tuesday for a vaccine at the state’s mass vaccination sites, and from April 19 at any vaccine provider in the state.

Also on Monday, Gov. Philip D. Murphy of New Jersey said residents 16 or older in his state would be eligible on April 19. Mayor Muriel Bowser of Washington said later on Monday that city residents 16 or older would also be eligible on April 19.

That leaves two states, Oregon and Hawaii, keeping to Mr. Biden’s original deadline of May 1. Their governors did not immediately respond to requests for comment about whether they would broaden eligibility sooner, but Gov. Kate Brown of Oregon announced on Monday that all frontline workers and their families, as well as those 16 or older with underlying health conditions, would be eligible immediately.

In Hawaii, 34 percent of residents have received at least one dose; in Oregon, the figure is 31 percent. Alabama has vaccinated the lowest proportion of its residents, at 25 percent.

But as Ms. Brown noted in her announcement about eligibility — and as experts have warned for weeks — “we’re in a race between vaccines and variants.”

Along with dangerous coronavirus variants that were identified in Britain, South Africa and Brazil, new mutations have continued to pop up in the United States, from California to New York to Oregon.

The shots will eventually win, scientists say, but because each infection gives the coronavirus a chance to evolve further, vaccinations must proceed as fast as possible.

As that race continues, the optimism sown by the steady pace of vaccinations may be threatening to undermine the progress the nation has made. Scientists also fear Americans could let their guard down too soon as warmer weather draws them outside and case levels drop far below the devastating surge this winter.

Cases are now rising sharply in parts of the country, with some states offering a stark reminder that the pandemic is far from over: New cases in Michigan have increased 112 percent and hospitalizations have increased 108 percent over the past two weeks, according to a New York Times database.

The United States is averaging more than 64,000 new cases each day, an 18 percent increase from two weeks earlier. That’s well below the peak of more than 250,000 new cases daily in January, but on par with last summer’s surge after reopenings in some states, like Arizona, where patrons packed into clubs as hospital beds filled up. The United States is averaging more than 800 Covid-19 deaths each day, the lowest level since November.

Yet again, governors across the country have lifted precautions like mask mandates and capacity limits on businesses. Medical experts have warned that these moves are premature, and Mr. Biden has urged governors to reinstate the restrictions.

Travel is up again, too, with more than one million people passing through airport security each day in the United States since March 11, according to the Transportation Security Administration. On Sunday, more than 1.5 million people passed through T.S.A. checkpoints. The C.D.C. said last week that fully vaccinated Americans could travel domestically with low risk, but should still follow precautions like wearing masks.

Several businesses in China are offering incentives for those getting inoculated, including this Lego stall outside a vaccination center in Beijing.
Credit…Gilles Sabrié for The New York Times

In Beijing, the vaccinated qualify for buy-one-get-one-free ice cream cones. In the northern province of Gansu, a county government published a 20-stanza poem extolling the virtues of the jab. In the southern town of Wancheng, officials warned parents that if they refused to get vaccinated, their children’s schooling and future employment and housing were all at risk.

China is deploying a medley of tactics, some tantalizing and some threatening, to achieve mass vaccination on a staggering scale: a goal of 560 million people, or 40 percent of its population, by the end of June.

China has already proven how effectively it can mobilize against the coronavirus. And other countries have achieved widespread vaccination, albeit in much smaller populations.

But China faces a number of challenges. The country’s near-total control over the coronavirus has left many residents feeling little urgency to get vaccinated. Some are wary of China’s history of vaccine-related scandals, a fear that the lack of transparency around Chinese coronavirus vaccines has done little to assuage. Then there is the sheer size of the population to be inoculated.

To get it done, the government has turned to a familiar tool kit: a sprawling, quickly mobilized bureaucracy and its sometimes heavy-handed approach. This top-down, all-out response helped tame the virus early on, and now the authorities hope to replicate that success with vaccinations.

Already, uptake has skyrocketed. Over the past week, China has administered an average of about 4.8 million doses a day, up from about one million a day for much of last month. Experts have said they hope to reach 10 million a day to meet the June goal.

“They say it’s voluntary, but if you don’t get the vaccine, they’ll just keep calling you,” said Annie Chen, a university student in Beijing who received two such entreaties from a school counselor in about a week.

Millions of people have received the AstraZeneca vaccine without safety problems, but reports of rare blood clots have raised concerns.
Credit…Alessandro Grassani for The New York Times

A top vaccines official at the European Medicines Agency said on Tuesday that AstraZeneca’s vaccine was linked to blood clots in a small number of recipients, the first indication from a leading regulatory body that the clots may be a real, if extremely rare, side effect of the shot.

The agency itself has not formally changed its guidance, issued last week, that the benefits of the AstraZeneca vaccine outweigh the risks, but any further ruling from regulators would be a setback for a shot that Europe and much of the world are relying on to save lives amid a global surge in coronavirus cases.

The medicines agency said last week that no causal link between the vaccine and rare blood clots had been proven. Only a few dozen cases of blood clots have been recorded among the many millions of people who have received the vaccine across Europe.

But the vaccines official, Marco Cavaleri, told an Italian newspaper that “it is clear there is an association with the vaccine,” and that the medicines agency would announce “in the next hours” that it had determined there was a link. The medicines agency did not immediately respond to questions about its plans.

Those comments represented the first indication by a leading regulatory body that the blood clots could be a genuine, if extremely rare, side effect of the AstraZeneca vaccine. Previously, health officials in several European countries temporarily restricted the use of the shot in certain age groups, despite the European Medicines Agency’s recommendation to keep administering it.

Regulators in Britain and at the World Health Organization have also said that, while they were investigating any rare side effects, the shot was safe to use and would save many lives.

Mr. Cavaleri told the Italian newspaper Il Messaggero that European regulators had not determined why the vaccine might be causing the rare blood clots, which generated concern because the cases were so unusual. They involved blood clots combined with unusually low levels of platelets, a disorder that can lead to heavy bleeding.

The most worrisome of the conditions, known as cerebral venous sinus thrombosis, involves clots in the veins that drain blood from the brain, a condition that can lead to a rare type of stroke.

The clots are, by all accounts, extremely rare. European regulators were analyzing 44 cases of cerebral venous sinus thrombosis, 14 of them fatal, among 9.2 million people who received the AstraZeneca vaccine across the continent. Emer Cooke, the European Medicines Agency’s director, said that the clotting cases in younger people translated to a risk for one in every 100,000 people under 60 given the vaccine. Younger people, and especially younger women, are at higher risk from the brain clots, scientists have said.

In Britain, regulators last week reported 30 cases of the rare blood clots combined with low platelets among 18 million people given the AstraZeneca vaccine, which was developed with the University of Oxford. No such cases were reported in people who had received the Pfizer-BioNTech vaccine in Britain.

Regulators in Britain have said that people should get the vaccine “when invited to do so.” But British news reports indicated Monday night that regulators were considering updating that guidance for certain age groups.

Monika Pronczuk and Emma Bubola contributed reporting.

The North Koreans at the closing ceremony for the 2018 Winter Games in Pyeongchang, South Korea.
Credit…Edgar Su/Reuters

North Korea said on Tuesday that it had decided not to participate in the Tokyo Olympic Games this summer because of the coronavirus pandemic.

The North’s national Olympic Committee decided at a March 25 meeting that its delegation would skip the Olympics “in order to protect our athletes from the global health crisis caused by the malicious virus infection,” according to Sports in the Democratic People’s Republic of Korea, a government-run website.

It is the first Summer Olympics that the North has missed since 1988, when they were held in Seoul, the South Korean capital.

North Korea, which has a decrepit public health system, has taken stringent measures against the virus since early last year, including shutting its borders. The country officially maintains that it has no virus cases, but outside health experts are skeptical.

North Korea’s decision deprives South Korea and other nations of a rare opportunity to establish official contact with the isolated country. Officials in the South had hoped that the Olympics — to be held from July 23 to Aug. 8 — might provide a venue for senior delegates from both Koreas to discuss issues beyond sports.

The 2018 Winter Olympics, held in the South Korean city of Pyeongchang, offered similar hope for easing tensions on the Korean Peninsula. Kim Yo-jong, the only sister of North Korea’s leader, Kim Jong-un, grabbed global attention when she attended the opening ceremony, becoming the first member of the Kim family to cross the border into South Korea.

Mr. Kim used the North’s participation in the Pyeongchang Olympics as a signal to start diplomacy after a series of nuclear and long-range missile tests. Inter-Korean dialogue soon followed, leading to three summit meetings between Mr. Kim and President Moon Jae-in of South Korea. Mr. Kim also met three times with President Donald J. Trump.

But since the collapse of Mr. Kim’s diplomacy with Mr. Trump in 2019, North Korea has shunned official contact with South Korea or the United States. The pandemic has deepened the North’s diplomatic isolation and economic difficulties amid concerns over its nuclear ambitions. North Korea launched two ballistic missiles on March 25 in its first such test in a year, in a challenge to President Biden.

Since North Korea’s first Olympic appearance in 1972, it has participated in every Summer Games except for the Los Angeles event in 1984, when it joined a Soviet-led boycott, and in 1988, when South Korea played host. North Korean athletes have won 16 gold medals, mostly in weight lifting, wrestling, gymnastics, boxing and judo, consistently citing the ruling Kim family as inspiration.

The Tokyo Games were originally scheduled for 2020 but were delayed by a year because of the pandemic. The organizing committee has been scrambling to develop safety protocols to protect both participants and local residents. But as a series of health, economic and political challenges have arisen, large majorities in Japan now say in polls that the Games should not be held this summer.

Even though organizers have barred international spectators, epidemiologists warn the Olympics could still become a superspreader event. Thousands of athletes and other participants will descend on Tokyo from more than 200 countries while much of the Japanese public remains unvaccinated.

The Australia-New Zealand travel bubble is expected to deliver a boost to tourism and to families that have been separated by strict border closures.
Credit…Matthew Abbott for The New York Times

Prime Minister Jacinda Ardern of New Zealand announced on Tuesday that her nation would establish a travel bubble with Australia, allowing travelers to move between the countries without needing to quarantine for the first time since the pandemic began.

The bubble, which will open just before midnight on April 19, is expected to deliver a boost to tourism and to families that have been separated since both countries enacted strict border closures and lockdown measures that have all but eliminated local transmission of the coronavirus.

The announcement came after months of negotiations and setbacks, as Australia battled small outbreaks and officials in both countries weighed testing requirements and other safety protocols.

“The director general of health considers the risk of transmission of Covid-19 from Australia to New Zealand is low and that quarantine-free travel is safe to commence,” Ms. Ardern said at a news conference.

Since last year, Australia has permitted travelers from New Zealand to bypass its hotel quarantine requirements. New Zealand’s decision to reciprocate makes the two countries among the first places in the world to set up such a bubble, following a similar announcement last week by Taiwan and the Pacific island nation of Palau.

Australians flying to New Zealand will be required to have spent the previous 14 days in Australia, to wear a mask on the plane and, if possible, to use New Zealand’s Covid-19 contact tracing app. In the event of an outbreak in Australia, New Zealand could impose additional restrictions, including shutting down travel to a particular Australian state or imposing quarantine requirements, Ms. Ardern said.

She warned that the new requirements would not necessarily free up many spaces in New Zealand’s overwhelmed hotel quarantine system, which has a weekslong backlog for New Zealanders wishing to book a space to return home. Of the roughly 1,000 slots that would now become available every two weeks, around half would be set aside as a contingency measure, while most of the others would not be appropriate for travelers from higher-risk countries, Ms. Ardern said.

Before New Zealand closed its borders to international visitors in March 2020, its tourism industry employed nearly 230,000 people and contributed 41.9 billion New Zealand dollars ($30.2 billion) to economic output, according to the country’s tourism board. Most of the roughly 3.8 million foreign tourists who visited New Zealand over a 12-month period between 2018 and 2019 came from Australia.

Ms. Ardern encouraged Australians to visit New Zealand’s ski areas, and said she would be conducting interviews with Australian media outlets this week to promote New Zealand as a tourism destination.

The bubble would also make it easier for the more than 500,000 New Zealanders who live in Australia to visit their families.

“It is ultimately a change of scene that so many have been looking for,” Ms. Ardern said, addressing Australians. “You may not have been in long periods of lockdown, but you haven’t had the option. Now you have the option, come and see us.”

Fans filled the seats on Monday for the Texas Rangers opening day game in Arlington, Texas, against the Toronto Blue Jays.
Credit…Tom Pennington/Getty Images

There was no need to pipe in crowd noise at Globe Life Field on Monday, as the Texas Rangers hosted the Toronto Blue Jays in front of the largest crowd at a sporting event in the United States in more than a year.

From the long lines of fans waiting to get into the stadium to the persistent buzz of the spectators during quiet moments, the game in Arlington, Texas, was a throwback to a time before the coronavirus crippled the country.

“It felt like a real game,” Rangers Manager Chris Woodward said. “It felt like back to the old days when we had full capacity.”

The official crowd of 38,238 fans, which was announced as a sellout, represented 94.8 percent of the stadium’s 40,300-seat capacity. It topped the Daytona 500 (which allowed slightly more than 30,000 fans) and the Super Bowl (24,835), both of which were held in February, as the largest crowd at a U.S. sporting event since the pandemic began last year.

The lifting of capacity restrictions in Texas made the enormous crowd possible. And for Major League Baseball, which claims its teams collectively lost billions during a largely fanless 2020 season, it was a hopeful sign that large crowds can return to all of the league’s games before too long. The open question is whether such events can be safe as the pandemic continues.

M.L.B. requires all fans over age 2 to wear masks at games this season, but a large percentage of the fans in Arlington went maskless. That will undoubtedly raise fears of the event resulting in a spike in coronavirus cases.

A garment worker in Cambodia signaled support for a campaign demanding relief for garment workers who have lost jobs and reform of the apparel industry, including a severance guarantee fund.
Credit…Enric Catala/Wsm

Garment workers in factories producing clothes and shoes for companies like Nike, Walmart and Benetton have seen their jobs disappear in the past 12 months, as major brands in the United States and Europe canceled or refused to pay for orders after the pandemic took hold and suppliers resorted to mass layoffs or closures.

Most garment workers earn chronically low wages, and few have any savings. Which means the only thing standing between them and dire poverty are legally mandated severance benefits that are often owed upon termination, wherever the workers are in the world.

According to a new report from the Worker Rights Consortium, however, garment workers are being denied some or all of these wages.

The study identified 31 export garment factories in nine countries where, the authors concluded, a total of 37,637 workers who were laid off did not receive the full severance pay they legally earned, a collective $39.8 million.

According to Scott Nova, the group’s executive director, the report covers only about 10 percent of global garment factory closures with mass layoffs in the last year. The group is investigating an additional 210 factories in 18 countries, leading the authors to estimate that the final data set will detail 213 factories with severance pay violations affecting more than 160,000 workers owed $171.5 million.

“Severance wage theft has been a longstanding problem in the garment industry, but the scope has dramatically increased in the last year,” Mr. Nova said. He added that the figures were likely to rise as economic aftershocks related to the pandemic continued to unfold across the retail industry. He believes the lost earnings could total between $500 million and $850 million.

The report’s authors say the only realistic solution to the crisis would be the creation of a so-called severance guarantee fund. The initiative, devised in conjunction with 220 unions and other labor rights organizations, would be financed by mandatory payments from signatory brands that could then be leveraged in cases of large-scale nonpayment of severance by a factory or supplier.

Several household names implicated in the report made money during the pandemic. Amazon, for example, reported an increase in net profit of 84 percent in 2020, while Inditex, the parent company of Zara, made 11.4 billion euros, about $13.4 billion, in gross profit. Nike, Next and Walmart all also had healthy earnings.

Some industry experts believe the purchasing practices of the industry’s power players are a major contributor to the severance pay crisis. The overwhelming majority of fashion retailers do not own their own production facilities, instead contracting with factories in countries where labor is cheap. The brands dictate prices, often squeezing suppliers to offer more for less, and can shift sourcing locations at will. Factory owners in developing countries say they are forced to operate on minimal margins, with few able to afford better worker wages or investments in safety and severance.

“The onus falls on the supplier,” said Genevieve LeBaron, a professor at the University of Sheffield in England who focuses on international labor standards. “But there is a reason the spotlight keeps falling on larger actors further up the supply chain. Their behavior can impact the ability of factories to deliver on their responsibilities.”

Jon Laster performing on Friday at the Comedy Cellar in Manhattan.
Credit…Jeenah Moon for The New York Times

More than a year after the pandemic brought down the curtain at theaters and concert halls around the world, the performing arts are beginning to return to the stage.

A smattering of theater and comedy shows lit up New York stages over the last few days, but next week will see one of the higher-profile arts returns. The New York Philharmonic is scheduled to give its first live performance in a concert hall since the pandemic began: “a musical musing on Goethe,” at the Shed at the Hudson Yards development on April 14.

The reopenings come at a confusing moment in the pandemic. Vaccinations are rising in the United States — Saturday was the first time the country reported more than four million doses in a single day, according to data compiled by The New York Times — but so are case counts.

While new cases, deaths and hospitalizations are far below their January peak, the average number of new reported cases has risen 19 percent over the past two weeks.

Still, performance spaces are carefully starting to welcome audiences, at a fraction of their capacity. There remains much debate over what regulations to impose on attendees. In Israel, concertgoers are required to have a Green Pass, which certifies that they have been vaccinated, though enforcement can be spotty.

In New York, as at the Daryl Roth Theater, an Off Broadway venue, temperatures were checked as a small audience streamed in for an immersive sound performance based on the José Saramago novel “Blindness” — a dystopian tale from 25 years ago whose resonances eerily align with the present. Mayor Bill de Blasio, masked and sneaker-clad, greeted some theatergoers on the sidewalk outside with wrist and elbow bumps.

But that optimism has been tinged with more halting news that underscores how fragile these reopenings are.

The Park Avenue Armory had to postpone one of the most high-profile experiments to bring indoor live performance back to New York. A sold-out run of “Afterwardsness,” a new piece that addresses the pandemic and violence against Black people, was canceled after several members of the Bill T. Jones/Arnie Zane Company tested positive for the virus.

At the Comedy Cellar, a Greenwich Village club that has nursed the early careers of many comics, laughter filled the room for its first show, but reminders of reality were impossible to miss: Performers’ microphones were swapped out between each set, every fresh one covered with what looked like a miniature shower cap.

John Touhey, 27, said that his reason for coming was simple. “Just to feel something again,” he said.California officials have announced guidelines for indoor concerts, theater, sports and other events, which will be permitted beginning April 15. Capacity will be linked to a county’s health tier.

Los Angeles County, for example, on Monday moved into the orange tier, which would allow venues that hold up to 1,500 people to operate at 15 percent capacity, or 200 people. The number rises to 35 percent if all attendees are tested or show proof of vaccination.

In Minneapolis, pandemic-weary music fans may have to wait longer, but the results will be louder. First Avenue, a legendary club, last month booked its first new, non-postponed show since the pandemic began, The Star Tribune reported. The band is Dinosaur Jr., led by J. Mascis, one of the most durable indie rockers of the last 30 years. The show is scheduled for Sept. 14.

“Those people have not been catered for,” said Dr. Raja Amjid Riaz, a surgeon who is a leader at the Central Mosque of Brent in North London.
Credit…Andrew Testa for The New York Times

Minority communities in Britain have long felt estranged from the government and medical establishment, but their sense of alienation is suddenly proving more costly than ever amid a coronavirus vaccination campaign that depends heavily on trust.

With Britons enjoying one of the fastest vaccination rollouts in the world, skepticism about the shots remains high in many of the communities where Covid-19 has taken the heaviest toll.

“The government’s response to the Black, Asian and minority ethnic communities has been rather limited,” said Dr. Raja Amjid Riaz, 52, a surgeon who is also a leader at the Central Mosque of Brent, an ethnically diverse area of North London. “Those people have not been catered for.”

As a result, communities like Brent offer fertile ground for the most outlandish of vaccine rumors, from unfounded claims that they affect fertility to the outright fabrication that shots are being used to inject microchips.

With the government seen as still disengaged in Black, Asian and other ethnic minority communities even as they have been hit disproportionately hard both by the virus itself and by the lockdowns imposed to stop its spread, many local leaders like Dr. Riaz have taken it upon themselves to act.

Some are well-known and trusted figures like religious leaders. Others are local health care workers. And still others are ordinary community members like Umit Jani, a 46-year-old Brent resident.

Mr. Jani’s face is one of many featured on 150 posters across the borough encouraging residents to get tested for the virus and vaccinated, part of a local government initiative.

The goal is to reframe the community’s relationship with the power structure, and perhaps establish some trust.

“In Brent, things have been done to communities and not in partnership,” said Mr. Jani, who said he had seen the toll the virus has taken on the area’s Gujarati and Somali communities.

A line for meals at the Bowery Mission in New York last month. Some people who would benefit most from the stimulus are having the hardest time getting it.
Credit…Andrew Seng for The New York Times

For most Americans, the third stimulus payment, like the first two, arrived as if by magic, landing unprompted in the bank or in the mail.

But it’s not as straightforward for people without a bank account or a mailing address. Or a phone. Or identification.

Just about anyone with a Social Security number who is not someone else’s dependent and who earns less than $75,000 is entitled to the stimulus. But some of the people who would benefit most from the money are having the hardest time getting their hands on it.

“There’s this great intention to lift people out of poverty more and give them support, and all of that’s wonderful,” said Beth Hofmeister, a lawyer for the Legal Aid Society’s Homeless Rights Project. “But the way people have to access it doesn’t really fit with how most really low-income people are interacting with the government.”

Interviews with homeless people in New York City over the last couple of weeks found that some mistakenly assumed they were ineligible for the stimulus. Others said that bureaucratic hurdles, complicated by limited phone or internet access, were insurmountable.

Paradoxically, the very poor are the most likely to pump stimulus money right back into devastated local economies, rather than sock it away in the bank or use it to play the stock market.

“I’d find a permanent place to stay, some food, clothing, a nice shower, a nice bed,” said Richard Rodriguez, 43, waiting for lunch outside the Bowery Mission last month. “I haven’t had a nice bed for a year.”

Mr. Rodriguez said he had made several attempts to file taxes — a necessary step for those not yet in the system — but had given up.

“I went to H&R Block and I told them I was homeless,” he said. “They said they couldn’t help me.”

People dining indoors in Northville, Mich., on Sunday. Coronavirus cases are rising even as restrictions are eased, with a more transmissible variant of the virus making up many of the cases in Michigan and elsewhere.
Credit…Emily Elconin/Reuters

U.S. coronavirus cases have increased again after hitting a low late last month, and some of the states driving the upward trend have also been hit hardest by variants, according to an analysis of data from Helix, a lab testing company.

The country’s vaccine rollout has sped up since the first doses were administered in December, recently reaching a rolling average of more than three million doses per day. And new U.S. cases trended steeply downward in the first quarter of the year, falling almost 80 percent from mid-January through the end of March.

But during that period, states also rolled back virus control measures, and now mobility data shows a rise in people socializing and traveling. Amid all this, more contagious variants have been gaining a foothold, and new cases are almost 20 percent higher than they were at the lowest point in March.

“It is a pretty complex situation, because behavior is changing, but you’ve also got this change in the virus itself at the same time,” said Emily Martin, an epidemiologist at the University of Michigan School of Public Health.

Michigan has seen the sharpest rise in cases in the last few weeks. B.1.1.7 — the more transmissible and more deadly variant of the coronavirus that was first discovered in Britain — may now make up around 70 percent of all of the state’s new cases, according to the Helix data.

Higher vaccination rates among the country’s older adults — those prioritized first in the vaccination rollout — mean that some of those at highest risk of complications are protected as cases rise again.

But almost 70 percent of the U.S. population has still not received a first dose, and only about half of those ages 65 and older are fully vaccinated. And in many states, those with high-risk conditions or in their 50s and 60s had not yet or had only just become eligible for the vaccine when cases began to rise again, leaving them vulnerable.

A gym in Saarbruecken, Germany, reopened on Tuesday to anyone with a negative coronavirus test in the previous 24 hours.
Credit…Oliver Dietze/DPA, via Associated Press

The tiny German state of Saarland, home to around 990,000 people, is making a cautious return to a new kind of normal in a pilot project that state officials hope could show how to keep the local economy open while controlling infections. From Tuesday, residents who test negative for the coronavirus will be able to use outdoor dining areas, gyms and movie theaters and even attend live theater performances.

Even as cases have continued to rise in Germany, prompting calls for a harsher national lockdown to halt a third wave of the pandemic — which has already shut down many of its European neighbors.

“More vaccinating, more testing, more mindfulness, more options: That’s the formula we want to use as Saarland break new ground in the fight against the coronavirus pandemic,” Tobias Hans, the governor of the state in southwestern Germany, said last week as he announced the reopening plans.

Under the guidelines, as many as 10 people can meet outdoors, and anyone with a negative test result within the previous 24 hours can visit stores, gyms, theaters and beer gardens — places that have largely been closed across Germany since the country announced a “lockdown light” in November.

(Many stores have been open since March, when a court overturned the rules.)

The Saarland project begins the same day that new regulations require travelers from the Netherlands to present a negative coronavirus test to cross the border into Germany. Travelers from the Czech Republic, France and Poland face similar measures.

View Source